U-shaped association between low-density lipid cholesterol and diabetes mellitus in patients with hypertension

[1]  C. Mao,et al.  Triglycerides Paradox Among the Oldest Old: “The Lower the Better?” , 2019, Journal of the American Geriatrics Society.

[2]  M. Khan,et al.  Association of Lowering Low‐Density Lipoprotein Cholesterol With Contemporary Lipid‐Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta‐Analysis , 2019, Journal of the American Heart Association.

[3]  Jun Lv,et al.  Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults , 2019, Nature Medicine.

[4]  M. Janghorbani,et al.  Low-density lipoprotein cholesterol and risk of type 2 diabetes: The Isfahan diabetes prevention study. , 2018, Diabetes & metabolic syndrome.

[5]  F. Rodríguez‐Artalejo,et al.  LDL Cholesterol Rises With BMI Only in Lean Individuals: Cross-sectional U.S. and Spanish Representative Data , 2018, Diabetes Care.

[6]  K. Bengtsson Boström,et al.  Relation Between Lipid Profile and New-Onset Atrial Fibrillation in Patients With Systemic Hypertension (From the Swedish Primary Care Cardiovascular Database [SPCCD]). , 2018, The American journal of cardiology.

[7]  Jian‐Jun Li,et al.  2016 Chinese guidelines for the management of dyslipidemia in adults , 2018, Journal of geriatric cardiology : JGC.

[8]  M. M. Mc Auley,et al.  LDL-C levels in older people: Cholesterol homeostasis and the free radical theory of ageing converge. , 2017, Medical hypotheses.

[9]  Sara M. Willems,et al.  Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis. , 2016, JAMA.

[10]  Huiqun Wu,et al.  Prevalence of type 2 diabetes mellitus among inland residents in China (2000–2014): A meta‐analysis , 2016, Journal of diabetes investigation.

[11]  A. Amin,et al.  Reverse Epidemiology of Traditional Cardiovascular Risk Factors in the Geriatric Population. , 2015, Journal of the American Medical Directors Association.

[12]  R. Mägi,et al.  Using Genetic Variants to Assess the Relationship Between Circulating Lipids and Type 2 Diabetes , 2015, Diabetes.

[13]  M. Kurano,et al.  Hepatic NPC1L1 overexpression ameliorates glucose metabolism in diabetic mice via suppression of gluconeogenesis. , 2015, Metabolism: clinical and experimental.

[14]  J. Kastelein,et al.  Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus. , 2015, JAMA.

[15]  Hynek Pikhart,et al.  HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials , 2015, The Lancet.

[16]  Yan Lin,et al.  Missing value imputation in high-dimensional phenomic data: imputable or not, and how? , 2014, BMC Bioinformatics.

[17]  L. Hassing,et al.  Body Mass Index, Change in Body Mass Index, and Survival in Old and Very Old Persons , 2013, Journal of the American Geriatrics Society.

[18]  J. Shaw,et al.  IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. , 2011, Diabetes research and clinical practice.

[19]  Li-sheng Liu,et al.  [2010 Chinese guidelines for the management of hypertension]. , 2011, Zhonghua xin xue guan bing za zhi.

[20]  B. Vergès.  Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes. , 2010, Atherosclerosis.

[21]  Yasuo Ohashi,et al.  Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials , 2010, The Lancet.

[22]  D. Corella,et al.  Metabolic syndrome pathophysiology: the role of adipose tissue. , 2008, Kidney international. Supplement.

[23]  R. Mayeux,et al.  Relationship Between Plasma Lipids and All‐Cause Mortality in Nondemented Elderly , 2005, Journal of the American Geriatrics Society.

[24]  K. Yano,et al.  Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study , 2001, The Lancet.

[25]  K Y Liang,et al.  Serum cholesterol in young men and subsequent cardiovascular disease. , 1993, The New England journal of medicine.

[26]  J. Dixon,et al.  Obesity Paradox in Hypertension: Is This Because Sympathetic Activation in Obesity-Hypertension Takes a Benign Form? , 2018, Hypertension.

[27]  R. Summer.  Obesity paradox? , 2013, American journal of respiratory and critical care medicine.

[28]  R. Blumenthal,et al.  LDL cholesterol: the lower the better. , 2012, The Medical clinics of North America.

[29]  J. Shaw,et al.  IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. , 2011, Diabetes research and clinical practice.

[30]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..